Collette Jane Behrens

Person

Macquarie Park, AU

People

Patents Grantslast 30 patents

Information Patent Grant
Interferon alpha 2B variants
- Patent number 11,319,356
- Issue date May 3, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 11,253,591
- Issue date Feb 22, 2022
- Teva Pharmaceuticals Australia Pty Ltd.
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 11,117,975
- Issue date Sep 14, 2021
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Interferon alpha 2B variants
- Patent number 10,544,199
- Issue date Jan 28, 2020
- Teva Pharmaceuticals Australia Pty Ltd.
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B
- Patent number 9,963,515
- Issue date May 8, 2018
- Teva Pharmaceuticals Australia Pty Ltd.
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of lenalidomide and polypeptide construct, and uses the...
- Patent number 9,636,334
- Issue date May 2, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20220220184
- Publication date Jul 14, 2022
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20200102364
- Publication date Apr 2, 2020
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20190151447
- Publication date May 23, 2019
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20180305460
- Publication date Oct 25, 2018
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...
- Publication number 20170202962
- Publication date Jul 20, 2017
- Teva Pharmaceuticals Australia Pty Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
INTERFERON ALPHA 2B VARIANTS
- Publication number 20160122410
- Publication date May 5, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Collette Behrens
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B
- Publication number 20160068612
- Publication date Mar 10, 2016
- Teva Pharmaceuticals Australia Pty Ltd
- Adam Clarke
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Combination of Lenalidomide and Polypeptide Construct, and Uses The...
- Publication number 20150313965
- Publication date Nov 5, 2015
- Teva Pharmaceuticals Australia Pty, Ltd
- Sarah L. Pogue
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Collette Jane Behrens

Person

Patents Grantslast 30 patents

Interferon alpha 2B variants

Combination of lenalidomide and polypeptide construct, and uses the...

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Interferon alpha 2B variants

Anti-CD38 antibodies and fusions to attenuated interferon alpha-2B

Combination of lenalidomide and polypeptide construct, and uses the...

Patents Applicationslast 30 patents

INTERFERON ALPHA 2B VARIANTS

INTERFERON ALPHA 2B VARIANTS

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

COMBINATION OF LENALIDOMIDE AND POLYPEPTIDE CONSTRUCT, AND USES THE...

INTERFERON ALPHA 2B VARIANTS

ANTI-CD38 ANTIBODIES AND FUSIONS TO ATTENUATED INTERFERON ALPHA-2B

Combination of Lenalidomide and Polypeptide Construct, and Uses The...